Pharmacological inhibition of Src family kinases attenuates hyperuricemic nephropathy
Hyperuricemia is an independent risk factor for chronic kidney disease and contributes to renal fibrosis. This study aims to investigate the effect of Src family kinase (SFK) inhibition on the development of hyperuricemic nephropathy (HN) and the mechanisms involved. In a rat model of HN, feeding ra...
Main Authors: | Chongxiang Xiong, Jin Deng, Xin Wang, Qidi Hou, Shougang Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1352730/full |
Similar Items
-
Progress on the role of NLRP3 inflammasome in hyperuricemic nephropathy
by: DAI Zhixin, WANG Yumin
Published: (2023-02-01) -
Advances in Research on Pathological and Molecular Mechanism of Hyperuricemic Nephropathy Based on Animal Models
by: BAO Fangqi, et al.
Published: (2024-04-01) -
Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging
by: Li He, et al.
Published: (2022-07-01) -
The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
by: Lore De Kock, et al.
Published: (2020-11-01) -
Establishment and optimization of a novel mouse model of hyperuricemic nephropathy
by: Jiamin Wang, et al.
Published: (2024-12-01)